New drug for ALS ready for clinical trials
Previous studies have suggested that a gene therapy drug may be used to treat ALS...
List view / Grid view
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
Previous studies have suggested that a gene therapy drug may be used to treat ALS...
A new drug has been developed to help prevent attacks of hereditary angioedema and at the same offer patients a convenient administration...
Silencing the gene behind the production of HSP90, a target in the HSF1 pathway, effectively kills leukaemia cells, without affecting healthy cells...
Drug discovery has always been challenging; today, more so than ever. While there has been success in addressing many diseases, others remain intractable...
How times change. Up to 15 years ago, you would be hard-pressed to find a drug discovery conference with a track dedicated to phenotypic approaches. The underpinning science was called high-content imaging or analysis, being mainly confined to academic drug discovery labs and a handful of pioneers in industry. but…
ATPliteTM and ATPlite 1step are robust, rapid, high-throughput luminescence assays used to assess a compound’s druggability.
The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, suggest new findings...
In today’s modern world, data is everywhere. This eBook will guide you through the steps of how to achieve more with accurate data.
Quickly and easily quantitate immune checkpoint markers using a fraction of the sample volume required by traditional ELISAs...
In this video, Becky Allsopp from Sygnature Discovery talks about Drug Discovery Research and how she uses the Microplate Reader PHERAstar FSX for their research.
AlphaLISA® provides a robust assay that facilitates the design and development of antibody therapeutics.
A new malaria vaccine targets the protein PMIF, which is crucial in the life cycle of malaria parasites...
This whitepaper explains how you can find ways to optimise the holistic preclinical development process...
In the annual report of the Chief Medical Officer, 1 Dame Sally Davies has declared that we are part of ‘generation genome’ – the era in which we reap the rewards of our advances in genomic technologies and improvements in our understanding of the whole genome in human health.
Researchers have conducted promising preclinical experiments on a compound that could be used to treat Wilson's disease...